HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease.

AbstractOBJECTIVE:
Sulforaphane is an activator of transcription factor NF-E2-related factor-2 (nrf2) that regulates gene expression through the promoter antioxidant response element (ARE). Nrf2 regulates the transcription of a battery of protective and metabolic enzymes. The aim of this study was to assess whether activation of nrf2 by sulforaphane in human microvascular endothelial cells prevents metabolic dysfunction in hyperglycemia.
RESEARCH DESIGN AND METHODS:
Human microvascular HMEC-1 endothelial cells were incubated in low and high glucose concentrations (5 and 30 mmol/l, respectively), and activation of nrf2 was assessed by nuclear translocation. The effects of sulforaphane on multiple pathways of biochemical dysfunction, increased reactive oxygen species (ROS) formation, hexosamine pathway, protein kinase C (PKC) pathway, and increased formation of methylglyoxal were assessed.
RESULTS:
Activation of nrf2 by sulforaphane induced nuclear translocation of nrf2 and increased ARE-linked gene expression, for example, three- to fivefold increased expression of transketolase and glutathione reductase. Hyperglycemia increased the formation of ROS-an effect linked to mitochondrial dysfunction and prevented by sulforaphane. ROS formation was increased further by knockdown of nrf2 and transketolase expression. This also abolished the counteracting effect of sulforaphane, suggesting mediation by nrf2 and related increase of transketolase expression. Sulforaphane also prevented hyperglycemia-induced activation of the hexosamine and PKC pathways and prevented increased cellular accumulation and excretion of the glycating agent methylglyoxal.
CONCLUSIONS:
We conclude that activation of nrf2 may prevent biochemical dysfunction and related functional responses of endothelial cells induced by hyperglycemia in which increased expression of transketolase has a pivotal role.
AuthorsMingzhan Xue, Qingwen Qian, Antonysunil Adaikalakoteswari, Naila Rabbani, Roya Babaei-Jadidi, Paul J Thornalley
JournalDiabetes (Diabetes) Vol. 57 Issue 10 Pg. 2809-17 (Oct 2008) ISSN: 1939-327X [Electronic] United States
PMID18633117 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Isothiocyanates
  • NF-E2-Related Factor 2
  • RNA, Small Interfering
  • Sulfoxides
  • Thiocyanates
  • Transketolase
  • sulforaphane
Topics
  • Active Transport, Cell Nucleus (drug effects)
  • Cell Line
  • Cell Nucleus (metabolism)
  • Endothelial Cells (cytology, drug effects, metabolism)
  • Flow Cytometry
  • Gene Expression (drug effects)
  • Humans
  • Hyperglycemia (metabolism, physiopathology)
  • Immunoblotting
  • Isothiocyanates
  • Microscopy, Confocal
  • NF-E2-Related Factor 2 (genetics, metabolism)
  • RNA, Small Interfering (genetics)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sulfoxides
  • Thiocyanates (pharmacology)
  • Transfection
  • Transketolase (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: